Synthetic AT may be divided into two main categories: (i) those that have been primarily developed and synthetized as AT and (ii) compounds that primarily act via different mechanisms of action, while their AT properties were discovered later, which may contribute to their biological activity (as observed for some clinically used drugs, e.g., 4-aminosalicylic acid with inflammatory bowel disease (IBD))
Additionally, L-arginine also competes with ADMA, an endogenous eNOS inhibitor (Boger et al., 1998c), thereby restoring the L-arginine/ADMA ratio that is critical for eNOS activity (Dong et al., 2011) (Figure 6)
3b) still form an ADPP i state, pointing to slow product release but intact ATP hydrolysis
It can directly scavenge diverse oxidants such as superoxide anion, nitric oxide, hydroxyl radical, and carbon radicals through the oxidation of GSH to its oxidized form, GSSG